Methods of treating cancer with anti-PD-1 antibodies
US12415855B2 · kind B2 · utility
0Cited by
33References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2022 |
| Grant date | Sep 16, 2025 |
| Priority date | — |
| Expiry date | Oct 16, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of administering certain PD-1 binding agents to patients having cancer. Dosage regimens for compositions comprising a PD-1 binding agent are also explicitly provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.